4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-023954
CHIEF OPERATING OFFICER sold 17,500 shares at $24.99 ($437,325)
- CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tessari Eben · CHIEF OPERATING OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-09-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $1.59 | $15,900 | 134,475 | D |
| 2024-09-23 | Sale : show line 2 in the form 10b5-1 | −17,500 | $24.99 | $437,325 | 116,975 | D |
| Open-market sales · 17,500 sh · avg $24.99 · $437,325 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-23 | Exercise or conversion : show line 3 in the form 10b5-1 Share Option | −10,000 | 36,017 | D |
Loading xslF345X05/form4-09252024_080916.xml…